The IRF5-TNPO3 association with systemic lupus erythematosus has two components that other autoimmune disorders variably share

Human Molecular Genetics

Volumn 24, Issue 2, 2015, Pages 582-596

  Kottyan, Leah C ^a,c   Zoller, Erin E ^a   Bene, Jessica ^a   Lu, Xiaoming ^a   Kelly, Jennifer A ^d   Rupert, Andrew M ^b   Lessard, Christopher J ^d,k   Vaughn, Samuel E ^a   Marion, Miranda ^e   Weirauch, Matthew T ^a,b,c   Namjou, Bahram ^a   Adler, Adam ^d   Rasmussen, Astrid ^d   Glenn, Stuart ^d   Montgomery, Courtney G ^d   Hirschfield, Gideon M ^g   Xie, Gang ^h   Coltescu, Catalina ⁱ   Amos, Chris ^j   Li, He ^d,k   Ice, John A ^d   Nath, Swapan K ^d   Mariette, Xavier ^l   Bowman, Simon ^m   Rischmueller, Maureen ⁿ   Lester, Sue ^n,o   Brun, Johan G ^p,q   Gøransson, Lasse G ^r   Harboe, Erna ^r   Omdal, Roald ^r   Cunninghame Graham, Deborah S ^s   Vyse, Tim ^s   Miceli Richard, Corinne ^l   Brennan, Michael T ^t   Lessard, James A ^u   Wahren Herlenius, Marie ^v   Kvarnström, Marika ^v   Illei, Gabor G ^w   Witte, Torsten ^x   Jonsson, Roland ^p,q   Eriksson, Per ^y   Nordmark, Gunnel ^z   Ng, Wan Fai ^aa   Anaya, Juan Manuel ^ab   Rhodus, Nelson L ^ac   Segal, Barbara M ^ad   Merrill, Joan T ^d   James, Judith A ^d,k   Guthridge, Joel M ^d   Scofield, R Hal ^d,k,ae   Alarcon Riquelme, Marta ^d,af   Bae, Sang Cheol ^ag   Boackle, Susan A ^ah   Criswell, Lindsey A ^ai   Gilkeson, Gary ^aj   Kamen, Diane L ^aj   Jacob, Chaim O ^ak   Kimberly, Robert ^al   Brown, Elizabeth ^al   Edberg, Jeffrey ^al   Alarcón, Graciela S ^al   Reveille, John D ^am   Vilá, Luis M ^an   Petri, Michelle ^ao   Ramsey Goldman, Rosalind ^ap   Freedman, Barry I ^f   Niewold, Timothy ^aq   Stevens, Anne M ^ar   Tsao, Betty P ^as   Ying, Jun ^at   Mayes, Maureen D ^at   Gorlova, Olga Y ^at   Wakeland, Ward ^au   Radstake, Timothy ^av   Martin, Ezequiel ^aw   Martin, Javier ^aw   Siminovitch, Katherine ^h,ax   Moser Sivils, Kathy L ^d   Gaffney, Patrick M ^d   Langefeld, Carl D ^e   Harley, John B ^a,c   Kaufman, Kenneth M ^a,c   more..

^a MLC 15012   (United States)

^b CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d OKLAHOMA MEDICAL RESEARCH FOUNDATION   (United States)

^e Department of Biostatistical Sciences and Center for Public Health Genomics ^*  (United States)

^f WAKE FOREST SCHOOL OF MEDICINE   (United States)

^g UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^h MOUNT SINAI HOSPITAL   (Canada)

ⁱ TORONTO WESTERN HOSPITAL   (Canada)

^j DARTMOUTH MEDICAL SCHOOL   (United States)

^k UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

^l INSERM   (France)

^m UNIVERSITY HOSPITALS BIRMINGHAM NHS FOUNDATION TRUST   (United Kingdom)

ⁿ QUEEN ELIZABETH HOSPITAL   (Australia)

^o UNIVERSITY OF ADELAIDE   (Australia)

^p UNIVERSITY OF BERGEN   (Norway)

^q HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^r STAVANGER UNIVERSITY HOSPITAL   (Norway)

^s KING'S COLLEGE LONDON   (United Kingdom)

^t CAROLINAS MEDICAL CENTER   (United States)

^u Valley Bone and Joint Clinic   (United States)

^v KAROLINSKA INSTITUTE   (Sweden)

^w NATIONAL INSTITUTE OF DENTAL AND CRANIOFACIAL RESEARCH   (United States)

^x HANNOVER MEDICAL SCHOOL   (Germany)

^y LINKÖPING UNIVERSITY   (Sweden)

^z UPPSALA UNIVERSITY   (Sweden)

^aa NEWCASTLE UNIVERSITY   (United Kingdom)

^ab UNIVERSIDAD DEL ROSARIO   (Colombia)

^ac UNIVERSITY OF MINNESOTA   (United States)

^ad UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^ae VETERANS AFFAIRS MEDICAL CENTER   (United States)

^af UNIVERSITY OF GRANADA   (Spain)

^ag Hanyang University Hospital for Rheumatic Diseases   (South Korea)

^ah UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^ai UNIVERSITY OF CALIFORNIA   (United States)

^aj MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^ak UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^al University of Alabama at Birmingham   (United States)

^am UNIVERSITY OF TEXAS   (United States)

^an UNIVERSITY OF PUERTO RICO MEDICAL SCIENCES CAMPUS   (Puerto Rico)

^ao JOHNS HOPKINS UNIVERSITY   (United States)

^ap NORTHWESTERN UNIVERSITY   (United States)

^aq MAYO CLINIC   (United States)

^ar SEATTLE CHILDREN S HOSPITAL   (United States)

^as UNIVERSITY OF CALIFORNIA   (United States)

^at UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^au UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^av RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^aw INSTITUTO DE PARASITOLOGÍA Y BIOMEDICINA LÓPEZ NEYRA   (Spain)

^ax UNIVERSITY OF TORONTO   (Canada)

more..

Author keywords

[No Author keywords available]

Indexed keywords

TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR ZBTB3; UNCLASSIFIED DRUG; DNA BINDING PROTEIN; INTERFERON REGULATORY FACTOR; IRF5 PROTEIN, HUMAN; KARYOPHERIN BETA; TNPO3 PROTEIN, HUMAN; ZBTB3 PROTEIN, HUMAN;

ALLELE; ANCESTRY GROUP; ARTICLE; AUTOIMMUNE DISEASE; BAYES THEOREM; CONTROLLED STUDY; DISEASE ASSESSMENT; DNA SEQUENCE; EUROPEAN; GENE; GENE EXPRESSION; GENE LOCUS; GENE MAPPING; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HUMAN; IRF5 GENE; MAJOR CLINICAL STUDY; PRIMARY BILIARY CIRRHOSIS; PRIORITY JOURNAL; PROMOTER REGION; SJOEGREN SYNDROME; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC SCLEROSIS; TNPO3 GENE; CASE CONTROL STUDY; COHORT ANALYSIS; GENETICS; MALE; SINGLE NUCLEOTIDE POLYMORPHISM;

AUTOIMMUNE DISEASES; BAYES THEOREM; BETA KARYOPHERINS; CASE-CONTROL STUDIES; COHORT STUDIES; DNA-BINDING PROTEINS; HAPLOTYPES; HUMANS; INTERFERON REGULATORY FACTORS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC;

EID: 84922444783     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddu455     Document Type: Article

References (75)

1. Hirschfield, G.M., Liu, X., Han, Y., Gorlov, I.P., Lu, Y., Xu, C., Chen, W., Juran, B.D., Coltescu, C., Mason, A.L. et al. (2010) Variants at IRF5-TNPO3, 17q12-21 and MMEL1 are associated with primary biliary cirrhosis. Nat. Genet., 42, 655-657.
2. Anderson, C.A., Boucher, G., Lees, C.W., Franke, A., D'Amato, M., Taylor, K.D., Lee, J.C., Goyette, P., Imielinski, M., Latiano, A. et al. (2011) Meta-analysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to 47. Nat. Genet., 43, 246-252.
3. Martin, J.E., Broen, J.C., Carmona, F.D., Teruel, M., Simeon, C.P., Vonk, M.C., van't Slot, R., Rodriguez-Rodriguez, L., Vicente, E., Fonollosa, V. et al. (2012) Identification of CSK as a systemic sclerosis genetic risk factor through Genome Wide Association Study follow-up. Hum. Mol. Genet., 21, 2825-2835.
4. Stahl, E.A., Raychaudhuri, S., Remmers, E.F., Xie, G., Eyre, S., Thomson, B.P., Li, Y., Kurreeman, F.A., Zhernakova, A., Hinks, A. et al. (2010) Genome-wide association study meta-analysis identifies seven new rheumatoid arthritis risk loci. Nat. Genet., 42, 508-514.
5. Miceli-Richard, C., Gestermann, N., Ittah, M., Comets, E., Loiseau, P., Puechal, X., Hachulla, E., Gottenberg, J.E., Lebon, P., Becquemont, L. et al. (2009) The CGGGG insertion/deletion polymorphism of the IRF5 promoter is a strong risk factor for primary Sjogren's syndrome. Arthritis Rheum., 60, 1991-1997.
6. Fan, J.H., Gao, L.B., Pan, X.M., Li, C., Liang, W.B., Liu, J., Li, Y. and Zhang, L. (2010) Association between IRF-5 polymorphisms and risk of acute coronary syndrome. DNA Cell Biol., 29, 19-23.
7. Kristjansdottir, G., Sandling, J.K., Bonetti, A., Roos, I.M., Milani, L., Wang, C., Gustafsdottir, S.M., Sigurdsson, S., Lundmark, A., Tienari, P.J. et al. (2008) Interferon regulatory factor 5 (IRF5) gene variants are associated with multiple sclerosis in three distinct populations. J. Med. Genet., 45, 362-369.
8. Vosslamber, S., van der Voort, L.F., van den Elskamp, I.J., Heijmans, R., Aubin, C., Uitdehaag, B.M., Crusius, J.B., van der Pouw Kraan, T.C., Comabella, M., Montalban, X. et al. (2012) Interferon regulatory factor 5 gene variants and pharmacological and clinical outcome of Interferonb therapy in multiple sclerosis. Genes Immun., 13, 443.
9. Uccellini, L., De Giorgi, V., Zhao, Y., Tumaini, B., Erdenebileg, N., Dudley, M.E., Tomei, S., Bedognetti, D., Ascierto, M.L., Liu, Q. et al. (2012) IRF5 gene polymorphisms in melanoma. J. Transl. Med., 10, 170.
10. Juran, B.D., Hirschfield, G.M., Invernizzi, P., Atkinson, E.J., Li, Y., Xie, G., Kosoy, R., Ransom, M., Sun, Y., Bianchi, I. et al. (2012) Immunochip analyses identify a novel risk locus for primary biliary cirrhosis at 13q14, multiple independent associations at four established risk loci and epistasis between 1p31 and 7q32 risk variants. Hum. Mol. Genet., 21, 5209-5221.
11. Harley, J.B., Alarcón-Riquelme, M.E., Criswell, L.A., Jacob, C.O., Kimberly, R.P., Moser, K.L., Tsao, B.P., Vyse, T.J. and Langefeld, C.D. (2008) Genome-wide association scan in women with systemic lupus erythematosus identifies susceptibility variants in ITGAM, PXK, KIAA1542 and other loci. Nat. Genet., 40, 204-210.
12. Cunninghame Graham, D.S., Manku, H., Wagner, S., Reid, J., Timms, K., Gutin, A., Lanchbury, J.S. and Vyse, T.J. (2007) Association of IRF5 in UK SLE families identifies a variant involved in polyadenylation. Hum. Mol. Genet., 16, 579-591.
13. Demirci, F.Y., Manzi, S., Ramsey-Goldman, R., Minster, R.L., Kenney, M., Shaw, P.S., Dunlop-Thomas, C.M., Kao, A.H., Rhew, E., Bontempo, F. et al. (2007) Association of a common interferon regulatory factor 5 (IRF5) variant with increased risk of systemic lupus erythematosus (SLE). Ann. Hum. Genet., 71, 308-311.
14. Ferreiro-Neira, I., Calaza, M., Alonso-Perez, E., Marchini, M., Scorza, R., Sebastiani, G.D., Blanco, F.J., Rego, I., Pullmann, R. Jr, Pullmann, R. et al. (2007) Opposed independent effects and epistasis in the complex association of IRF5 to SLE. Genes Immun., 8, 429-438.
15. Gateva, V., Sandling, J.K., Hom, G., Taylor, K.E., Chung, S.A., Sun, X., Ortmann, W., Kosoy, R., Ferreira, R.C., Nordmark, G. et al. (2009) A large-scale replication study identifies TNIP1, PRDM1, JAZF1, UHRF1BP1 and IL10 as risk loci for systemic lupus erythematosus. Nat. Genet., 41, 1228-1233.
16. Graham, R.R., Kyogoku, C., Sigurdsson, S., Vlasova, I.A., Davies, L.R., Baechler, E.C., Plenge, R.M., Koeuth, T., Ortmann, W.A., Hom, G. et al. (2007) Three functional variants of IFN regulatory factor 5 (IRF5) define risk and protective haplotypes for human lupus. Proc. Natl. Acad. Sci. USA, 104, 6758-6763.
17. Han, J.W., Zheng, H.F., Cui, Y., Sun, L.D., Ye, D.Q., Hu, Z., Xu, J.H., Cai, Z.M., Huang, W., Zhao, G.P. et al. (2009) Genome-wide association study in a Chinese Han population identifies nine new susceptibility loci for systemic lupus erythematosus. Nat. Genet., 41, 1234-1237.
18. Jarvinen, T.M., Hellquist, A., Zucchelli, M., Koskenmies, S., Panelius, J., Hasan, T., Julkunen, H., D'Amato, M. and Kere, J. (2012) Replication of GWAS-identified systemic lupus erythematosus susceptibility genes affirms B-cell receptor pathway signalling and strengthens the role of IRF5 in disease susceptibility in a Northern European population. Rheumatology (Oxford), 51, 87-92.
19. Kawasaki, A., Kyogoku, C., Ohashi, J., Miyashita, R., Hikami, K., Kusaoi, M., Tokunaga, K., Takasaki, Y., Hashimoto, H., Behrens, T.W. et al. (2008) Association of IRF5 polymorphisms with systemic lupus erythematosus in a Japanese population: support for a crucial role of intron 1 polymorphisms. Arthritis Rheum., 58, 826-834.
20. Kelly, J.A., Kelley, J.M., Kaufman, K.M., Kilpatrick, J., Bruner, G.R., Merrill, J.T., James, J.A., Frank, S.G., Reams, E., Brown, E.E. et al. (2008) Interferon regulatory factor-5 is genetically associated with systemic lupus erythematosus in African Americans. Genes Immun., 9, 187-194.
21. Lofgren, S.E., Yin, H., Delgado-Vega, A.M., Sanchez, E., Lewen, S., Pons-Estel, B.A., Witte, T., D'Alfonso, S., Ortego-Centeno, N., Martin, J. et al. (2010) Promoter insertion/deletion in the IRF5 gene is highly associated with susceptibility to systemic lupus erythematosus in distinct populations, but exerts a modest effect on gene expression in peripheral blood mononuclear cells. J. Rheumatol., 37, 574-578.
22. Nordang, G.B., Viken, M.K., Amundsen, S.S., Sanchez, E.S., Flato, B., Forre, O.T., Martin, J., Kvien, T.K. and Lie, B.A. (2012) Interferon regulatory factor 5 gene polymorphism confers risk to several rheumatic diseases and correlates with expression of alternative thymic transcripts. Rheumatology (Oxford), 51, 619-626.
23. Qin, L., Lv, J., Zhou, X., Hou, P., Yang, H. and Zhang, H. (2010) Association of IRF5 gene polymorphisms and lupus nephritis in a Chinese population. Nephrology (Carlton), 15, 710-713.
24. Reddy, M.V., Velazquez-Cruz, R., Baca, V., Lima, G., Granados, J., Orozco, L. and Alarcon-Riquelme, M.E. (2007) Genetic association of IRF5 with SLE in Mexicans: higher frequency of the risk haplotype and its homozygozity than Europeans. Hum. Genet., 121, 721-727.
25. Shin, H.D., Sung, Y.K., Choi, C.B., Lee, S.O., Lee, H.W. and Bae, S.C. (2007) Replication of the genetic effects of IFN regulatory factor 5 (IRF5) on systemic lupus erythematosus in a Korean population. Arthritis Res. Ther., 9, R32.
26. Sigurdsson, S., Goring, H.H., Kristjansdottir, G., Milani, L., Nordmark, G., Sandling, J.K., Eloranta, M.L., Feng, D., Sangster-Guity, N., Gunnarsson, I. et al. (2008) Comprehensive evaluation of the genetic variants of interferon regulatory factor 5 (IRF5) reveals a novel 5 bp length polymorphism as strong risk factor for systemic lupus erythematosus. Hum. Mol. Genet., 17, 872-881.
27. Sigurdsson, S., Nordmark, G., Goring, H.H., Lindroos, K., Wiman, A.C., Sturfelt, G., Jonsen, A., Rantapaa-Dahlqvist, S., Moller, B., Kere, J. et al. (2005) Polymorphisms in the tyrosine kinase 2 and interferon regulatory factor 5 genes are associated with systemic lupus erythematosus. Am. J. Hum. Genet., 76, 528-537.
28. Siu, H.O., Yang, W., Lau, C.S., Chan, T.M., Wong, R.W., Wong, W.H., Lau, Y.L. and Alarcon-Riquelme, M.E. (2008) Association of a haplotype of IRF5 gene with systemic lupus erythematosus in Chinese. J. Rheumatol., 35, 360-362.
29. Yang, W., Shen, N., Ye, D.Q., Liu, Q., Zhang, Y., Qian, X.X., Hirankarn, N., Ying, D., Pan, H.F., Mok, C.C. et al. (2010) Genome-wide association study in Asian populations identifies variants in ETS1 and WDFY4 associated with systemic lupus erythematosus. PLoS Genet., 6, e1000841.
30. Cham, C.M., Ko, K. and Niewold, T.B. (2012) Interferon regulatory factor 5 in the pathogenesis of systemic lupus erythematosus. Clin. Dev. Immunol., 2012, 780436.
31. Feng, D., Yang, L., Bi, X., Stone, R.C., Patel, P. and Barnes, B.J. (2012) Irf5-deficient mice are protected from pristane-induced lupus via increased Th2 cytokines and altered IgG class switching. Eur. J. Immunol., 42, 1477-1487.
32. Tada, Y., Kondo, S., Aoki, S., Koarada, S., Inoue, H., Suematsu, R., Ohta, A., Mak, T.W. and Nagasawa, K. (2011) Interferon regulatory factor 5 is critical for the development of lupus in MRL/lpr mice. Arthritis Rheum., 63, 738-748.
33. Yang, L., Feng, D., Bi, X., Stone, R.C. and Barnes, B.J. (2012) Monocytes from Irf5-/- mice have an intrinsic defect in their response to pristane-induced lupus. J. Immunol., 189, 3741-3750.
34. Larue, R., Gupta, K., Wuensch, C., Shkriabai, N., Kessl, J.J., Danhart, E., Feng, L., Taltynov, O., Christ, F., Van Duyne, G.D. et al. (2012) Interaction of the HIV-1 intasome with transportin 3 protein (TNPO3 or TRN-SR2). J. Biol. Chem., 287, 34044-34058.
35. Wellcome Trust Case Control Consortium, Maller, J.B., McVean, G., Byrnes, J., Vukcevic, D., Palin, K., Su, Z., Howson, J.M., Auton, A., Myers, S. et al. (2012) Bayesian refinement of association signals for 14 loci in 3 common diseases. Nat. Genet., 44, 1294-1301.
36. Dideberg, V., Kristjansdottir, G., Milani, L., Libioulle, C., Sigurdsson, S., Louis, E., Wiman, A.C., Vermeire, S., Rutgeerts, P., Belaiche, J. et al. (2007) An insertion-deletion polymorphism in the interferon regulatory factor 5 (IRF5) gene confers risk of inflammatory bowel diseases. Hum. Mol. Genet., 16, 3008-3016.
37. Graham, R.R., Kozyrev, S.V., Baechler, E.C., Reddy, M.V., Plenge, R.M., Bauer, J.W., Ortmann, W.A., Koeuth, T., Gonzalez Escribano, M.F., Pons-Estel, B. et al. (2006) A common haplotype of interferon regulatory factor 5 (IRF5) regulates splicing and expression and is associated with increased risk of systemic lupus erythematosus. Nat. Genet., 38, 550-555.
38. Feng, D., Stone, R.C., Eloranta, M.L., Sangster-Guity, N., Nordmark, G., Sigurdsson, S., Wang, C., Alm, G., Syvanen, A.C., Ronnblom, L. et al. (2010) Genetic variants and disease-associated factors contribute to enhanced interferon regulatory factor 5 expression in blood cells of patients with systemic lupus erythematosus. Arthritis Rheum., 62, 562-573.
39. Hedl, M. and Abraham, C. (2012) IRF5 risk polymorphisms contribute to interindividual variance in pattern recognition receptor-mediated cytokine secretion in human monocyte-derived cells. J. Immunol., 188, 5348-5356.
40. Niewold, T.B., Kelly, J.A., Kariuki, S.N., Franek, B.S., Kumar, A.A., Kaufman, K.M., Thomas, K., Walker, D., Kamp, S., Frost, J.M. et al. (2012) IRF5 haplotypes demonstrate diverse serological associations which predict serum interferon alpha activity and explain the majority of the genetic association with systemic lupus erythematosus. Ann. Rheum. Dis., 71, 463-468.
41. Farrell, G.C. (2008) Primary biliary cirrhosis in Asians: less common than in Europeans, but just as depressing. J. Gastroenterol. Hepatol., 23, 508-511.
42. Nakamura, M., Nishida, N., Kawashima, M., Aiba, Y., Tanaka, A., Yasunami, M., Nakamura, H., Komori, A., Nakamuta, M., Zeniya, M. et al. (2012) Genome-wide association study identifies TNFSF15 and POU2AF1 as susceptibility loci for primary biliary cirrhosis in the Japanese population. Am. J. Hum. Genet., 91, 721-728.
43. Niewold, T.B., Kelly, J.A., Flesch, M.H., Espinoza, L.R., Harley, J.B. and Crow, M.K. (2008) Association of the IRF5 risk haplotype with high serum interferon-alpha activity in systemic lupus erythematosus patients. Arthritis Rheum., 58, 2481-2487.
44. Rullo, O.J., Woo, J.M., Wu, H., Hoftman, A.D., Maranian, P., Brahn, B.A., McCurdy, D., Cantor, R.M. and Tsao, B.P. (2010) Association of IRF5 polymorphisms with activation of the interferon alpha pathway. Ann. Rheum. Dis., 69, 611-617.
45. Guthridge, J.M., Clark, D.N., Templeton, A., Dominguez, N., Lu, R., Vidal, G.S., Kelly, J.A., Kauffman, K.M., Harley, J.B., Gaffney, P.M. et al. (2012) Effects of IRF5 lupus risk haplotype on pathways predicted to influence B cell functions. J. Biomed. Biotechnol., 2012, 594056.
46. Malarstig, A., Sigurdsson, S., Eriksson, P., Paulsson-Berne, G., Hedin, U., Wallentin, L., Siegbahn, A., Hamsten, A. and Syvanen, A.C. (2008) Variants of the interferon regulatory factor 5 gene regulate expression of IRF5 mRNA in atherosclerotic tissue but are not associated with myocardial infarction. Arterioscler. Thromb. Vasc. Biol., 28, 975-982.
47. Alonso-Perez, E., Suarez-Gestal, M., Calaza, M., Kwan, T., Majewski, J., Gomez-Reino, J.J. and Gonzalez, A. (2011) Cis-regulation of IRF5 expression is unable to fully account for systemic lupus erythematosus association: analysis of multiple experiments with lymphoblastoid cell lines. Arthritis Res. Ther., 13, R80.
48. Kozyrev, S.V., Lewen, S., Reddy, P.M., Pons-Estel, B., Witte, T., Junker, P., Laustrup, H., Gutierrez, C., Suarez, A., Francisca Gonzalez-Escribano, M. et al. (2007) Structural insertion/deletion variation in IRF5 is associated with a risk haplotype and defines the precise IRF5 isoforms expressed in systemic lupus erythematosus. Arthritis Rheum., 56, 1234-1241.
49. Wen, F., Ellingson, S.M., Kyogoku, C., Peterson, E.J. and Gaffney, P.M. (2011) Exon 6 variants carried on systemic lupus erythematosus (SLE) risk haplotypes modulate IRF5 function. Autoimmunity, 44, 82-89.
50. Alonso-Perez, E., Fernandez-Poceiro, R., Lalonde, E., Kwan, T., Calaza, M., Gomez-Reino, J.J., Majewski, J. and Gonzalez, A. (2013) Identification of three new cis-regulatory IRF5 polymorphisms: in vitro studies. Arthritis Res. Ther., 15, R82.
51. Wingender, E., Dietze, P., Karas, H. and Knuppel, R. (1996) TRANSFAC: a database on transcription factors and their DNA binding sites. Nucleic Acids Res., 24, 238-241.
52. Sandelin, A., Alkema, W., Engstrom, P., Wasserman, W.W. and Lenhard, B. (2004) JASPAR: an open-access database for eukaryotic transcription factor binding profiles. Nucleic Acids Res, 32, D91-D94.
53. Newburger, D.E. and Bulyk, M.L. (2009) UniPROBE: an online database of protein binding microarray data on protein-DNAinteractions. Nucleic Acids Res., 37, D77-D82.
54. Jolma, A., Yan, J., Whitington, T., Toivonen, J., Nitta, K.R., Rastas, P., Morgunova, E., Enge, M., Taipale, M., Wei, G. et al. (2013) DNA-binding specificities of human transcription factors. Cell, 152, 327-339.
55. Skipper, M., Dhand, R. and Campbell, P. (2012) Presenting ENCODE. Nature, 489, 45.
56. Sankararaman, S., Mallick, S., Dannemann, M., Prufer, K., Kelso, J., Paabo, S., Patterson, N. and Reich, D. (2014) The genomiclandscape of Neanderthal ancestry in present-day humans. Nature, 507, 354-357.
57. Rasmussen, A., Sevier, S., Kelly, J.A., Glenn, S.B., Aberle, T., Cooney, C.M., Grether, A., James, E., Ning, J., Tesiram, J. et al. (2011) The lupus family registry and repository. Rheumatology (Oxford), 50, 47-59.
58. Hochberg, M.C. (1997) Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum, 40, 1725.
59. Hoggart, C.J., Parra, E.J., Shriver, M.D., Bonilla, C., Kittles, R.A., Clayton, D.G. and McKeigue, P.M. (2003) Control of confounding of genetic associations in stratified populations. Am. J. Hum. Genet., 72, 1492-1504.
60. Lessard, C.J., Adrianto, I., Kelly, J.A., Kaufman, K.M., Grundahl, K.M., Adler, A., Williams, A.H., Gallant, C.J., Anaya, J.M., Bae, S.C. et al. (2011) Identification of a systemic lupus erythematosus susceptibility locus at 11p13 between PDHX and CD44 in amultiethnic study. Am. J. Hum. Genet., 88, 83-91.
61. Hoggart, C.J., Shriver, M.D., Kittles, R.A., Clayton, D.G. and McKeigue, P.M. (2004) Design and analysis of admixture mapping studies. Am. J. Hum. Genet., 74, 965-978.
62. Smith, M.W., Patterson, N., Lautenberger, J.A., Truelove, A.L., McDonald, G.J., Waliszewska, A., Kessing, B.D., Malasky, M.J., Scafe, C., Le, E. et al. (2004) A high-density admixture map for disease gene discovery in African Americans. Am. J. Hum. Genet., 74, 1001-1013.
63. McKeigue, P.M., Carpenter, J.R., Parra, E.J. and Shriver, M.D. (2000) Estimation of admixture and detection of linkage in admixed populations by a Bayesian approach: application to African-American populations. Ann. Hum. Genet., 64, 171-186.
64. Price, A.L., Patterson, N.J., Plenge, R.M., Weinblatt, M.E., Shadick, N.A. and Reich, D. (2006) Principal components analysis corrects for stratification in genome-wide association studies. Nat. Genet., 38, 904-909.
65. Halder, I., Shriver, M., Thomas, M., Fernandez, J.R. and Frudakis, T. (2008) A panel of ancestry informative markers for estimating individual biogeographical ancestry and admixture from four continents: utility and applications. Hum. Mutat., 29, 648-658.
66. Purcell, S., Neale, B., Todd-Brown, K., Thomas, L., Ferreira, M.A., Bender, D., Maller, J., Sklar, P., de Bakker, P.I., Daly, M.J. et al. (2007) PLINK:a tool set for whole-genome association and population-based linkage analyses. Am. J. Hum. Genet., 81, 559-575.
67. Marchini, J., Howie, B., Myers, S., McVean, G. and Donnelly, P. (2007) A new multipoint method for genome-wide association studies by imputation of genotypes. Nat. Genet., 39, 906-913.
68. Barrett, J.C. (2009) Haploview: visualization and analysis of SNP genotype data. Cold Spring Harb. Protoc., 2009. http://cshprotocols.cshlp.org/content/
69. Barrett, J.C., Fry, B., Maller, J. and Daly, M.J. (2005) Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics, 21, 263-265.
70. Sankararaman, S., Sridhar, S., Kimmel, G. and Halperin, E. (2008) Estimating local ancestry in admixed populations. Am. J. Hum. Genet., 82, 290-303.
71. Lessard, C.J., Li, H., Adrianto, I., Ice, J.A., Rasmussen, A., Grundahl, K.M., Kelly, J.A., Dozmorov, M.G., Miceli-Richard, C., Bowman, S. et al. (2013) Variants at multiple loci implicated in both innate and adaptive immune responses are associated with Sjogren's syndrome. Nat. Genet., 45, 1284-1292.
72. Stephens, M. and Balding, D.J. (2009) Bayesian statistical methods for genetic association studies. Nat. Rev. Genet., 10, 681-690.
73. Lessard, C.J., Adrianto, I., Ice, J.A., Wiley, G.B., Kelly, J.A., Glenn, S.B., Adler, A.J., Li, H., Rasmussen, A., Williams, A.H. et al. (2012) Identification of IRF8, TMEM39A, and IKZF3-ZPBP2 as susceptibility loci for systemic lupus erythematosus in a large-scale multiracial replication study. Am. J. Hum. Genet., 90, 648-660.
74. Altshuler, D.M., Gibbs, R.A., Peltonen, L., Dermitzakis, E., Schaffner, S.F., Yu, F., Bonnen, P.E., de Bakker, P.I., Deloukas, P., Gabriel, S.B. et al. (2010) Integrating common and rare genetic variation in diverse human populations. Nature, 467, 52-58.
75. Radstake, T.R., Gorlova, O., Rueda, B., Martin, J.E., Alizadeh, B.Z., Palomino-Morales, R., Coenen, M.J., Vonk, M.C., Voskuyl, A.E., Schuerwegh, A.J. et al. (2010) Genome-wide association study of systemic sclerosis identifies CD247 as a new susceptibility locus. Nat. Genet., 42, 426-429.